$4.81
-0.01-0.21%
After Hours: 4:00 PM EDT
Comments
Loading...
Vanda Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VNDA | Benzinga
Vanda Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.020
Quarterly Revenue Estimate
$61.02M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$198.77M
Analyze the earnings history of Vanda Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharma | -$0.07 | -$0.02 | — | — | $47.46M | $61.02M | — | — | 05/07/2025 | Get Alert |
| VNDA | Vanda Pharma | -$0.04 | -$0.14 | -$0.08 | 42.86% | $45.27M | $51.00M | $53.19M | 4.28% | 02/13/2025 | Get Alert |
| VNDA | Vanda Pharma | $0.00 | -$0.16 | -$0.09 | 43.75% | $38.81M | $49.15M | $47.65M | -3.05% | 11/06/2024 | Get Alert |
| VNDA | Vanda Pharma | $0.03 | -$0.21 | -$0.08 | 61.90% | $46.06M | $47.86M | $50.47M | 5.46% | 07/31/2024 | Get Alert |
| VNDA | Vanda Pharma | $0.06 | $0.05 | -$0.07 | -240.00% | $62.50M | $48.50M | $47.46M | -2.14% | 05/08/2024 | Get Alert |
| VNDA | Vanda Pharma | $0.12 | -$0.09 | -$0.04 | 55.56% | $64.48M | $37.00M | $45.27M | 22.35% | 02/07/2024 | Get Alert |
| VNDA | Vanda Pharma | $0.06 | -$0.04 | $0.00 | 100.00% | $65.32M | $44.50M | $38.81M | -12.78% | 11/08/2023 | Get Alert |
| VNDA | Vanda Pharma | $0.05 | -$0.13 | $0.03 | 123.08% | $64.39M | $49.00M | $46.06M | -6.01% | 07/27/2023 | Get Alert |
| VNDA | Vanda Pharma | -$0.11 | — | $0.06 | — | $60.19M | — | $62.50M | — | 05/03/2023 | Get Alert |
| VNDA | Vanda Pharma | $0.12 | $0.08 | $0.12 | 50.00% | $68.02M | $67.60M | $64.48M | -4.61% | 02/08/2023 | Get Alert |
| VNDA | Vanda Pharma | $0.14 | $0.09 | $0.06 | -33.33% | $70.09M | $71.00M | $65.32M | -8.00% | 11/02/2022 | Get Alert |
| VNDA | Vanda Pharma | $0.17 | $0.11 | $0.05 | -54.55% | $67.90M | $67.00M | $64.39M | -3.90% | 08/03/2022 | Get Alert |
| VNDA | Vanda Pharma | $0.15 | -$0.01 | -$0.11 | -1000.00% | $62.67M | $58.00M | $60.19M | 3.78% | 05/05/2022 | Get Alert |
| VNDA | Vanda Pharma | $0.15 | $0.08 | $0.12 | 50.00% | $67.65M | $70.04M | $68.02M | -2.89% | 02/23/2022 | Get Alert |
| VNDA | Vanda Pharma | $0.11 | $0.16 | $0.14 | -12.50% | $60.31M | $75.00M | $70.09M | -6.54% | 11/03/2021 | Get Alert |
| VNDA | Vanda Pharma | $0.16 | $0.14 | $0.17 | 21.43% | $62.21M | $69.75M | $67.90M | -2.65% | 07/28/2021 | Get Alert |
| VNDA | Vanda Pharma | $0.01 | $0.15 | $0.15 | 0.00% | $58.00M | $68.50M | $62.67M | -8.51% | 05/05/2021 | Get Alert |
| VNDA | Vanda Pharma | $0.08 | $0.14 | $0.15 | 7.14% | $60.93M | $64.00M | $67.65M | 5.71% | 02/10/2021 | Get Alert |
| VNDA | Vanda Pharma | $0.23 | $0.09 | $0.11 | 22.22% | $59.48M | $63.95M | $60.31M | -5.70% | 10/28/2020 | Get Alert |
| VNDA | Vanda Pharma | $0.21 | — | $0.16 | — | $59.06M | $61.95M | $62.21M | 0.41% | 08/05/2020 | Get Alert |
| VNDA | Vanda Pharma | $0.06 | — | $0.01 | — | $47.71M | $56.87M | $58.00M | 1.99% | 05/06/2020 | Get Alert |
Vanda Pharmaceuticals (VNDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $-0.08 | $-0.14 | 42.9 % |
| Q3 | 2024-11-06 | $-0.09 | $-0.16 | 43.8 % |
| Q2 | 2024-07-31 | $-0.08 | $-0.21 | 61.9 % |
| Q1 | 2024-05-08 | $-0.07 | $0.05 | -240.0 % |
Vanda Pharmaceuticals (VNDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $53.19M | $51.00M | 4.28 % |
| Q3 | 2024-11-06 | $47.65M | $49.15M | -3.05 % |
| Q2 | 2024-07-31 | $50.47M | $47.86M | 5.46 % |
| Q1 | 2024-05-08 | $47.46M | $48.50M | -2.14 % |
FAQ
When is Vanda Pharmaceuticals (NASDAQ:VNDA) reporting earnings?
Vanda Pharmaceuticals (VNDA) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Vanda Pharmaceuticals (NASDAQ:VNDA)?
The Actual EPS was $-0.08, which beat the estimate of $-0.14.
What were Vanda Pharmaceuticals’s (NASDAQ:VNDA) revenues?
The Actual Revenue was $53.2M, which beat the estimate of $51M.
Browse earnings estimates, EPS, and revenue on all stocks.